ArticleTherapeutic advances in gastroenterology2011

Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease.

Chadwick Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.